<DOC>
	<DOCNO>NCT01999582</DOCNO>
	<brief_summary>To determine optimal route administration , dose level , safety intravenous subcutaneous dose sotatercept maintain hemoglobin level subject hemodialysis .</brief_summary>
	<brief_title>A Phase 2 Study Intravenous Subcutaneous Dosing Sotatercept ( ACE-011 ) Patients With End-Stage Kidney Disease Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>1 . Males females ≥ 18 year age . 2 . Subjects least 6 hour hemodialysis per week , least 12 week screen 3 . Subjects must stable intravenous subcutaneous dose Erythropoietin Stimulating Agents ( exclude methoxy polyethylene glycolepoetin beta [ Mircera ] ) maintain hemoglobin . 4 . A mean predialysis hemoglobin concentration ≥ 10 g/dL ( grams per deciliter ) ≤ 12 g/dL ( ≥ 100 g/L ( grams per liter ) ≤ 120 g/L ) obtain three consecutive day . 4 . A Body Mass Index value ≥ 18.5 kg/m2 ( kilogram per m2 ) screening . 5 . Understand voluntarily sign informed consent document prior study related assessments/procedures conduct . 6 . Able adhere study visit schedule comply protocol requirement . 1 . Non renal cause anemia 2 . Subjects peritoneal dialysis . 3 . Systemic hematological disease 4 . Uncontrolled diabetes mellitus ( HbA1c ( hemoglobin A1c ) &gt; 9 % ) screening . 5 . Uncontrolled hypertension define mean home systolic blood pressure &gt; 160 mm Hg ( millimeter mercury ) mean home diastolic blood pressure &gt; 90 mm Hg calculate screening period prior randomization 6 . Subjects heart failure 7 . History malignancy ( except excise cured nonmelanoma skin cancer , cervical carcinoma situ surgically ablate 5 year ago ) . 8 . Anticipated schedule live donor renal transplant course study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Anemia</keyword>
	<keyword>End Stage Kidney Disease</keyword>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Erythrpoietin Stimulating Agent ( ESA )</keyword>
</DOC>